Search
Searching Content indexed under M&A/Private Equity by Karen Taylor ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
The M&A Game – Big Pharma Prefers Not To Play
As seen in our recent report "Measuring the return on pharmaceutical innovation", the majority of big pharma’s late stage pipeline value is driven by external sources: Acquisitions; joint ventures or in-licensing agreements.
UK
10 Feb 2014
Links to Result pages
 
1